000 | 01836 a2200541 4500 | ||
---|---|---|---|
005 | 20250515225756.0 | ||
264 | 0 | _c20101116 | |
008 | 201011s 0 0 eng d | ||
022 | _a1029-2403 | ||
024 | 7 |
_a10.3109/10428194.2010.494316 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aStrullu, Marion | |
245 | 0 | 0 |
_aSilent hypersensitivity to Escherichia coli asparaginase in children with acute lymphoblastic leukemia. _h[electronic resource] |
260 |
_bLeukemia & lymphoma _cAug 2010 |
||
300 |
_a1464-72 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAntibodies, Anti-Idiotypic _ximmunology |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aAsparaginase _xadverse effects |
650 | 0 | 4 |
_aAsparagine _xmetabolism |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDrug Hypersensitivity |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 |
_aEscherichia coli _xenzymology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xblood |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aCorradini, Nadège | |
700 | 1 | _aAudrain, Marie | |
700 | 1 | _aOrsonneau, Jean-Luc | |
700 | 1 | _aBouige, Daniel | |
700 | 1 | _aThomare, Patrick | |
700 | 1 | _aVermot-Desroches, Claudine | |
700 | 1 | _aMansuy, Adeline | |
700 | 1 | _aLegrand, Arnaud | |
700 | 1 | _aRozé, Jean-Christophe | |
700 | 1 | _aMohty, Mohamad | |
700 | 1 | _aMéchinaud, Françoise | |
773 | 0 |
_tLeukemia & lymphoma _gvol. 51 _gno. 8 _gp. 1464-72 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428194.2010.494316 _zAvailable from publisher's website |
999 |
_c19895200 _d19895200 |